Brief: Sharon Bio-Medicine API Facility Gets 4 Form 483 Observations By USFDA
Feb 22 (Reuters) - Sharon Bio-Medicine Ltd SHBM.NS :
* CO'S API FACILITY AT TALOJA, MAHARASHTRA GOT 4 FORM 483
OBSERVATIONS POST INSPECTION BY USFDA ON FEBRUARY 22
Source text : https://www.bseindia.com/xml-data/corpfiling/AttachLive/7cdfc94e-9f4f-4012-90b9-bb961866f21d.pdf
Further company coverage: SHBM.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Sharon Bio-Medicine
See all newsBrief: Sharon Bio-Medicine Says Operations At Manufacturing Unit In Maharashtra Have Been Suspended Due To Fire Accident
Brief: India's Sharon Bio-Medicine Dec-Quarter Profit Rises
Brief: Sharon Bio-Medicine Trade Union In API Manufacturing Facility At Taloja, Mumbai Has Given Call For Indefinite Strike From Jan 3
Brief: India's Sharon Bio-Medicine Ltd Sept-Quarter Profit Rises
Media: Piramal, Cadila among 32 companies in race to buy India's Sharon Bio-Medicine - ET